PTEN Cancer Research Results

PTEN, phosphatase and tensin homolog; phosphatase and tensin homolog pseudogene 1: Click to Expand ⟱
Source: CGL-Driver Genes
Type: TSG
PTEN (Phosphatase and Tensin Homolog) is a crucial tumor suppressor gene that plays a significant role in regulating cell growth, proliferation, and survival. It encodes a protein that functions as a phosphatase, which means it removes phosphate groups from specific molecules, thereby regulating various signaling pathways, particularly the PI3K/AKT pathway.
PTEN is mutated, deleted, or otherwise inactivated. This loss of function can lead to increased cell proliferation and survival, contributing to tumorigenesis. PTEN mutations are commonly found in various cancers, including:
Prostate cancer
Breast cancer
Endometrial cancer
Glioblastoma
Scientific Papers found: Click to Expand⟱
3368- QC,    The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update
- Review, Var, NA
*Inflam↓, *antiOx↑, *AntiCan↑, Casp3↓, p‑Akt↓, p‑mTOR↓, p‑ERK↓, β-catenin/ZEB1↓, Hif1a↓, AntiAg↓, VEGFR2/KDR/Flk1↓, EMT↓, EGFR↓, MMP2↓, MMP↓, TumMeta↓, MMPs↓, Akt↓, Snail↓, N-cadherin↓, Vim↓, E-cadherin↑, STAT3↓, TGF-β↓, ROS↓, P53↑, BAX↑, PKCδ↓, PI3K↓, COX2/PTGS2↓, cFLIP↓, cycD1/CCND1↓, cMyc↓, IL6↓, IL10↓, Cyt‑c↑, TumCCA↑, DNMTs↓, HDAC↓, ac‑H3↑, ac‑H4↑, Diablo↑, Casp3↑, Casp9↑, PARP1↑, Synergy↑, PTEN↑, VEGF↓, NO↓, iNOS↓, ChemoSen↑, Synergy↑, Synergy↑, Synergy↑, uPA↓, CXCR4↓, CXCL12↓, CLDN2↓, CDK6↓, MMP9↓, TSP-1↑, Ki-67↓, PCNA↓, ROS↑, ER Stress↑,
3378- QC,    CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia
- in-vitro, AML, NA
CK2↓, PI3K↓, TumCD↑, Akt↓, Mcl-1↓, PTEN↑,
62- QC,  GoldNP,    Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231)
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
EGFR↓, PI3k/Akt/mTOR↓, GSK‐3β↓, TumCP↓, Apoptosis↑, tumCV↓, mTOR↓, PTEN↑,
100- QC,    Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes
- in-vitro, Pca, PC3 - in-vitro, Pca, DU145 - in-vitro, Pca, LNCaP
cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4/6↓, E2Fs↓, PCNA↓, cDC2↓, PTEN↑, MSH2↑, P21↑, EP300↑, BRCA1↑, NF2↑, TSC1↑, TGFβR1↑, P53↑, RB1↑, AKT1↓, cMyc↓, CDC7↓, cycF↓, CDC16↓, CUL4B↑, CBP↑, TSC2↑, HER2/EBBR2↓, BCR↓, TumCCA↑, chemoPv↑,
7150- RES,    Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity
- Review, Var, NA
AntiTum↑, PI3K↓, Akt↓, *AntiAge↑, *SIRT1↑, *lipid-P↓, *ROS↓, *BioAv↓, *NRF2↑, *HO-1↑, SOD↑, HDAC1↓, PTEN↑, P53↑, TumCCA↑, TumCI↓, TumMeta↓, EMT↓, MMPs↓, MMP9↓, angioG↓, VEGF↓, EGFR↓, FGF21↓, HIF-1↓, *neuroP↑, *cardioP↑, BMPs↑, ROS↑, Vim↓, N-cadherin↓, MMP3↓, MMP13↓, E-cadherin↑, Ki-67↓,
2687- RES,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, NA, NA - Review, AD, NA
NF-kB↓, P450↓, COX2/PTGS2↓, Hif1a↓, VEGF↓, *SIRT1↑, SIRT1↓, SIRT2↓, ChemoSen⇅, cardioP↑, *memory↑, *angioG↑, *neuroP↑, STAT3↓, CSCs↓, RadioS↑, Nestin↓, Nanog↓, TP53↑, P21↑, CXCR4↓, *BioAv↓, EMT↓, Vim↓, Slug↓, E-cadherin↑, AMPK↑, MDR1↓, DNAdam↑, TOP2↓, PTEN↑, Akt↓, Wnt↓, β-catenin/ZEB1↓, cMyc↓, MMP7↓, MALAT1↓, TCF↓, ALDH↓, CD44↓, Shh↓, IL6↓, VEGF↓, Synergy↑, HK2↓, ROS↑, MMP↓,
2443- RES,    Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
- Review, Var, NA
*antiOx↑, *ROS↓, *PTEN↑, *Akt↓, *Catalase↑, *SOD↑, *ERK↓, *GSH↑, *AMPK↑, *FOXO1↝, *RNS↓, *Catalase↑, *cardioP↑, *PI3K↑, *eNOS↑, hepatoP↑,
2441- RES,    Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
- Review, Var, NA
*toxicity↓, *BioAv↝, *Dose↝, *hepatoP↑, *neuroP↑, *AntiAg↑, *COX2/PTGS2↓, *antiOx↑, *ROS↓, *ROS↑, PI3K↓, Akt↓, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, NRF2↑, GPx↑, HO-1↑, BioEnh?, PTEN↑, ChemoSen↑, eff↑, mt-ROS↑, Warburg↓, Glycolysis↓, GlucoseCon↓, GLUT1↓, lactateProd↓, HK2↓, EGFR↓, cMyc↓, ROS↝, MMPs↓, MMP7↓, survivin↓, TumCP↓, TumCMig↓, TumCI↓,
3076- RES,    Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
- Review, Var, NA
IL6↓, MMPs↓, MMP2↓, MMP9↓, BioAv↓, Half-Life↑, BioAv↑, Dose↝, angioG↓, IL10↓, VEGF↓, NF-kB↓, COX2/PTGS2↓, SIRT1↑, Wnt↓, cMyc↓, STAT3↓, PTEN↑, ROS↑, RadioS↑, Hif1a↓, E-cadherin↓, Vim↓, angioG↓,
3055- RES,    Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
- Review, Var, NA
BioAv↓, BioAv↓, Dose↑, eff↑, eff↑, Dose↑, BioAv↑, ROS↑, MMP↓, P21↑, p27/CDKN1B↑, TumCCA↑, ChemoSen↑, COX2/PTGS2↓, 5LO↓, VEGF↓, IL1↓, IL6↓, IL8↓, AR↓, PSA↓, MAPK↓, Hif1a↓, Glycolysis↓, miR-21↓, PTEN↑, Half-Life↝, *IGF-1↓, *IGFBP3↑, Half-Life↓,
3006- RosA,    Rosmarinic acid attenuates glioblastoma cells and spheroids’ growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosis
- in-vitro, GBM, U87MG - in-vitro, GBM, LN229
TumCG↓, EMT↓, SIRT1↓, FOXO1↓, NF-kB↓, angioG↓, ROS↓, PTEN↓, PI3K↓, Akt↓, *Inflam↓, *cardioP↑, *hepatoP↑, *neuroP↑, Warburg↓,
3328- SIL,    Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB
- in-vivo, BPH, NA
*NF-kB↓, *Hif1a↓, *PTEN↑, *Weight↓, *NO↓, *IL6↓, *IL8↓, *COX2/PTGS2↓, *iNOS↓,
2197- SK,    Shikonin derivatives for cancer prevention and therapy
- Review, Var, NA
ROS↑, Ca+2↑, BAX↑, Bcl-2↓, MMP9↓, NF-kB↓, PKM2↓, Hif1a↓, NRF2↓, P53↑, DNMT1↓, MDR1↓, COX2/PTGS2↓, VEGF↓, EMT↓, MMP7↓, MMP13↓, uPA↓, RIP1↑, RIP3↑, Casp3↑, Casp7↑, Casp9↑, P21↓, DFF45↓, TRAIL↑, PTEN↑, mTOR↓, AR↓, FAK↓, Src↓, Myc↓, RadioS↑,
2183- SK,    Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1
- in-vitro, Thyroid, TPC-1
TumCMig↓, TumCI↓, PTEN↑, DNMT1↓,
3049- SK,    Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling
- in-vivo, Nor, NA - NA, Stroke, NA
*neuroP↑, *p‑PTEN↓, *p‑Akt↑, *Bcl-2↑, *BAX↓, *cognitive↑, *BDNF↑,
2127- TQ,    Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways
- Review, GBM, NA
chemoP↑, ChemoSen↑, BioAv↑, PTEN↑, PI3K↓, Akt↓, TumCCA↓, NF-kB↓, p‑Akt↓, p65↓, XIAP↓, Bcl-2↓, COX2/PTGS2↓, VEGF↓, mTOR↓, RAS↓, Raf↓, MEK↓, ERK↓, MMP2↓, MMP9↓, TumCMig↓, TumCI↓, Casp↑, cl‑PARP↑, ROS⇅, ROS↑, MMP↓, Synergy↑, Telomerase↓, DNAdam↑, Apoptosis↑, STAT3↓, RadioS↑,
2129- TQ,  doxoR,    Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells
- in-vitro, BC, MCF7
ChemoSen↑, PTEN↑, p‑Akt↓, TumCCA↑, P53↑, P21↑, Apoptosis↑, MMP↓, Casp↑, cl‑PARP↑, Bax:Bcl2↑, eff↓, DNAdam↓, p‑γH2AX↑, ROS↑,
2084- TQ,    Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
- Review, Var, NA
*ROS↓, *chemoPv↑, ROS↑, ROS⇅, MUC4↓, selectivity↑, AR↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, survivin↓, Mcl-1↓, VEGF↓, cl‑PARP↑, ROS↑, HSP70/HSPA5↑, P53↑, miR-34a↑, Rac1↓, TumCCA↑, NOTCH↓, NF-kB↓, IκB↓, p‑p65↓, IAP1↓, IAP2/BIRC3↑, XIAP↓, TNF-α↓, COX2/PTGS2↓, Inflam↓, α-tubulin↓, Twist↓, EMT↓, mTOR↓, PI3K↓, Akt↓, BioAv↓, ChemoSen↑, CompStab↑, PTEN↑, chemoPv↑, RadioS↑, *Half-Life↝, *BioAv↝,
8465- TQ,  docx,    Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells
- in-vitro, BC, NA
ChemoSen?, ROS↑, eff↓, Bcl-2↓, PI3K↓, AKT1↓, BAX↑, Casp9↑, PTEN↑,
4565- TQ,    Thymoquinone in the clinical treatment of cancer: Fact or fiction?
- Review, BC, NA
Dose↝, TumCCA↑, P21↑, cycD1/CCND1↓, TumCI↑, TumMeta↓, Bcl-2↓, Bcl-xL↓, survivin↓, PTEN↑, Akt↓, P53↑, NF-kB↓, cardioP↑, Dose↝,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2/PTGS2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
3422- TQ,    Thymoquinone, as a Novel Therapeutic Candidate of Cancers
- Review, Var, NA
selectivity↑, P53↑, PTEN↑, NF-kB↓, PPARγ↓, cMyc↓, Casp↑, *BioAv↓, CompStab↝, Synergy↑, survivin↓, Bcl-xL↓, Bcl-2↓, Akt↓, BAX↑, cl‑PARP↑, CXCR4↓, MMP9↓, VEGFR2/KDR/Flk1↓, Ki-67↓, COX2/PTGS2↓, JAK2↓, cSrc↓, Apoptosis↑, p‑STAT3↓, cycD1/CCND1↓, Casp3↑, Casp7↑, Casp9↑, N-cadherin↓, Vim↓, Twist↓, E-cadherin↑, ChemoSen↑, Synergy↑, EMT↓, ROS↑, DNMT1↓, Synergy↑, EZH2↓, hepatoP↑, Zeb1↓, RadioS↑, HDAC↓, HDAC1↓, HDAC2↓, HDAC3↓, *NAD↑, *SIRT1↑, SIRT1↓, *Inflam↓, *CRP↓, *TNF-α↓, *IL6↓, *IL1β↓, *Synergy↑, *MDA↓, *NO↓, *GSH↑, *SOD↑, *Catalase↑, *GPx↑, PI3K↓, mTOR↓,
3425- TQ,    Advances in research on the relationship between thymoquinone and pancreatic cancer
- in-vitro, PC, NA
Apoptosis↑, TumCP↓, TumCI↓, TumMeta↓, ChemoSen↑, angioG↓, Inflam↓, NF-kB↓, PI3K↓, Akt↓, TGF-β↓, Jun↓, p38↑, MAPK↑, MMP9↓, PKM2↓, ROS↑, JNK↑, MUC4↓, TGF-β↑, Dose↝, FAK↓, NOTCH↓, PTEN↑, mTOR↓, Warburg↓, XIAP↓, COX2/PTGS2↓, Casp9↑, Ki-67↓, CD34↓, VEGF↓, MCP1/CCL2↓, survivin↓, Cyt‑c↑, Casp3↑, H4↑, HDAC↓,
3423- TQ,    Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics
- Review, Var, NA
AntiCan↑, Inflam↓, hepatoP↑, RenoP↑, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓, ROS↑, P53↑, PTEN↑, P21↑, p27/CDKN1B↑, BRCA1↑, PI3K↓, Akt↓, MAPK↓, ERK↓, p‑ERK↓, MMPs↓, FAK↓, Twist↓, Zeb1↓, EMT↓, TumMeta↓, angioG↓, VEGF↓, HDAC↓, Maspin↑, SIRT1↑, DNMT1↓, DNMT3A↓, HDAC1↓, HDAC4↓,
4862- Uro,    Neuroprotective effect of Urolithin A via downregulating VDAC1-mediated autophagy in Alzheimer's disease
- in-vivo, AD, NA - in-vitro, Nor, PC12
*cognitive↑, *p‑PI3K↓, *p‑Akt↓, *AMPK↑, *VDAC1↓, *neuroP↑, *PARK2↑, *PTEN↑, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p62↓, *Aβ↓, *Apoptosis↓,

Showing Research Papers: 101 to 125 of 125
Prev Page 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 125

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 1,   Catalase↓, 3,   Catalase↑, 1,   Copper↑, 1,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 3,   GSH↓, 7,   GSR↓, 1,   GSTs↓, 1,   H2O2↑, 1,   HO-1↓, 3,   HO-1↑, 6,   HO-2↓, 1,   Iron↑, 1,   Iron↝, 1,   lipid-P↓, 1,   lipid-P↑, 3,   MDA↑, 2,   NQO1↓, 1,   NQO1↑, 1,   NRF2↓, 5,   NRF2↑, 6,   NRF2↝, 1,   p‑NRF2↓, 1,   Prx4↑, 1,   ROS↓, 9,   ROS↑, 50,   ROS⇅, 3,   ROS↝, 2,   i-ROS↑, 1,   mt-ROS↑, 2,   SAM-e↝, 1,   SOD↓, 3,   SOD↑, 2,   SOD2↓, 2,   SOD2↑, 1,   TAC↓, 1,   TOS↑, 1,   Trx↓, 1,   TrxR↓, 2,   VitC↓, 1,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR↓, 1,   CDC16↓, 1,   CDC2↓, 1,   CDC25↓, 4,   compIV↓, 1,   mtDam↑, 6,   OCR↓, 1,   OCR↑, 1,   PDH↓, 1,   PDH↑, 1,   SDH↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ACLY↓, 2,   ALAT↓, 2,   AminoA↓, 1,   AMPK↑, 5,   ATP↓, 3,   ATP:AMP↓, 1,   CAIX/CA9↓, 2,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   ECAR↝, 1,   ECAR∅, 1,   FASN↑, 2,   FBPase↑, 1,   glucoNG↑, 1,   GlucoseCon↓, 5,   GlutMet↓, 1,   Glycolysis↓, 16,   GSK‐3β↓, 6,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 1,   HK2↓, 12,   HMG-CoA↓, 1,   lactateProd↓, 5,   LDHA↓, 6,   LDL↓, 1,   NAD↝, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 6,   PFK1↓, 3,   PFK2?, 1,   PFK2↓, 2,   PIP3↑, 1,   PKM2↓, 3,   PLA2↓, 1,   SIRT1↓, 6,   SIRT1↑, 3,   SIRT2↓, 1,   TCA↓, 2,   TCA↑, 1,   Warburg↓, 5,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   Apoptosis↑, 38,   Apoptosis↝, 1,   ASC↓, 1,   ASK1↑, 1,   BAD↑, 3,   Bak↑, 3,   BAX↓, 2,   BAX↑, 31,   BAX↝, 1,   Bax:Bcl2↑, 5,   Bcl-2↓, 37,   Bcl-2↑, 1,   Bcl-2↝, 1,   Bcl-xL↓, 14,   Bcl-xL↑, 1,   Bcl-xL↝, 1,   BID↑, 1,   BIM↑, 2,   Casp↑, 6,   Casp1↓, 1,   Casp10↓, 1,   Casp2↑, 3,   Casp3↓, 1,   Casp3↑, 42,   Casp3↝, 1,   cl‑Casp3↑, 3,   Casp6↑, 1,   Casp7↑, 6,   Casp8↓, 1,   Casp8↑, 11,   Casp9↑, 33,   cl‑Casp9↑, 1,   cFLIP↓, 1,   Cyt‑c↑, 19,   Cyt‑c↝, 1,   Diablo↑, 3,   DR5↑, 5,   FADD↑, 1,   Fas↑, 2,   FasL↑, 2,   Ferroptosis↑, 4,   IAP1↓, 4,   IAP2/BIRC3↓, 2,   IAP2/BIRC3↑, 1,   iNOS↓, 5,   Mcl-1↓, 9,   MDM2↓, 4,   p‑MDM2↓, 1,   MEG3↑, 1,   necrosis↑, 2,   NOXA↑, 2,   p38↓, 1,   p38↑, 3,   p‑p38↑, 2,   Paraptosis↑, 1,   PUMA↓, 1,   PUMA↑, 2,   RIP3↑, 1,   survivin↓, 17,   TRAIL↑, 1,   TRAILR↑, 1,   TumCD↑, 1,   XIAP↓, 13,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ADCY4↑, 1,   Akt↓, 54,   Akt↑, 2,   Akt↝, 1,   p‑Akt↓, 26,   AKT1↓, 3,   AMPKα↑, 1,   BRAF↑, 1,   BRAF↝, 1,   CDC7↓, 1,   CK2↓, 2,   cSrc↓, 2,   EGFR↓, 13,   EGFR↑, 1,   EGFR↝, 1,   ERK↓, 9,   ERK↑, 3,   p‑ERK↓, 8,   p‑ERK↑, 1,   FGFR1↓, 2,   FGFR2↓, 1,   HER2/EBBR2↓, 3,   HGF/c-Met↓, 3,   HRAS↓, 1,   IGF-1R↓, 5,   p‑IGF-1R↓, 1,   IGF-2R↑, 2,   IKKα↓, 2,   IKKα↑, 1,   IκB↓, 1,   JAK↓, 3,   JAK1↓, 3,   JAK1↑, 1,   JAK2↓, 5,   JNK↑, 7,   JNK↝, 1,   p‑JNK↑, 2,   MAPK↓, 10,   MAPK↑, 3,   MAPK↝, 1,   MEK↓, 2,   p‑MEK↓, 1,   mTOR↓, 29,   mTOR⇅, 1,   mTOR↝, 1,   p‑mTOR↓, 7,   p70S6↓, 1,   PI3K↓, 45,   PI3K↝, 1,   p‑PI3K↓, 1,   PI3K/Akt↓, 1,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↓, 2,   PKA↓, 1,   PKCδ↓, 4,   PTEN↓, 11,   PTEN↑, 97,   PTEN↝, 2,   p‑PTEN↓, 2,   PTPN6↑, 1,   Raf↓, 3,   RAS↓, 5,   RIP1↑, 1,   p‑S6K↓, 1,   SHP1↑, 2,   Sp1/3/4↓, 2,   Src↓, 2,   p‑Src↓, 1,   STAT3↓, 23,   p‑STAT3↓, 4,   p‑STAT3↑, 2,   STAT6↓, 1,   p‑STAT6↓, 1,   TSC2↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↑, 2,   ATF4↝, 1,   CBP↑, 1,   p‑cJun↑, 1,   cMyc↓, 14,   DNMT1↓, 6,   DNMT3A↓, 3,   DNMTs↓, 5,   EZH2↓, 5,   FOXM1↓, 1,   FOXO1↓, 1,   FOXO1↑, 1,   FOXO3↓, 2,   FOXO3↑, 1,   FOXO4↑, 1,   H3↓, 2,   ac‑H3↑, 1,   H4↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HDAC↓, 11,   HDAC1↓, 6,   HDAC11↓, 1,   HDAC2↓, 3,   HDAC3↓, 2,   HDAC4↓, 2,   HDAC6↓, 1,   HES1↓, 1,   HMTs↓, 1,   JPT1/HN1↓, 1,   LINC01116↓, 1,   miR-106b↓, 1,   miR-10b-5p↓, 1,   miR-182-5p↓, 1,   miR-19b↓, 3,   miR-21↓, 5,   miR-27a-3p↓, 1,   miR-34a↑, 2,   miR-592↑, 1,   MTA2↓, 1,   Myc↓, 3,   n-MYC↓, 1,   OCT4↓, 2,   other↓, 1,   other↝, 1,   RUNX2↓, 1,   SOX2↓, 3,   SOX4↓, 1,   SOX4↑, 1,   SOX9?, 1,   SOX9↓, 1,   tumCV↓, 8,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↑, 7,   eIF2α↑, 2,   p‑eIF2α↑, 2,   ER Stress↑, 8,   Erlin1↑, 1,   HSP70/HSPA5↑, 1,   HSP90↓, 1,   IRE1↑, 1,   PERK↑, 2,   UPR↑, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 3,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3A↑, 1,   LC3B-II↑, 1,   LC3II↓, 2,   LC3II↑, 1,   NEU1↑, 1,   p62↓, 2,   PARK2↑, 1,   TumAuto↓, 1,   TumAuto↑, 7,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

BRCA1↑, 2,   CUL4B↑, 1,   DFF45↓, 1,   DNAdam↓, 2,   DNAdam↑, 11,   DNArepair↓, 1,   DNArepair↑, 1,   G9a↓, 1,   hTERT/TERT↓, 5,   MSH2↑, 1,   p16↑, 1,   P53↓, 1,   P53↑, 27,   P53↝, 1,   p73↑, 1,   PARP↑, 7,   cl‑PARP↑, 19,   PARP1↑, 1,   cl‑PARP1↑, 1,   PCNA↓, 4,   SIRT6↑, 1,   Telomerase↓, 5,   TOP2↓, 2,   TP53↑, 3,   γH2AX↑, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   CDK2↓, 7,   CDK2↑, 1,   CDK4↓, 10,   CDK4/6↓, 1,   CDK6↓, 6,   CDK7↓, 1,   CDK8↓, 1,   CDKN1C/p57↓, 1,   CDKN1C/p57↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   Cyc↝, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 3,   CycB/CCNB1↑, 1,   cycD1/CCND1↓, 19,   cycD1/CCND1↝, 1,   cycE/CCNE↓, 4,   cycF↓, 1,   E2Fs↓, 1,   Ki-67↓, 8,   P21↓, 2,   P21↑, 16,   P21↝, 1,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 8,   RB1↑, 1,   p‑RB1↓, 2,   Securin↓, 1,   TumCCA↓, 1,   TumCCA↑, 37,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 2,   Axin2↑, 1,   BMPs↑, 1,   CD133↓, 2,   CD34↓, 2,   cFos↑, 1,   CSCs↓, 5,   Diff↓, 1,   EP300↑, 1,   FGF↓, 2,   Gli1↓, 1,   HMGCR↓, 1,   IGF-1↓, 2,   JAG1↓, 1,   JAG1↑, 1,   Jun↓, 1,   Ki-67↓, 8,   Let-7↑, 1,   mTORC1↓, 3,   p‑mTORC1↓, 1,   Nanog↓, 2,   Nestin↓, 2,   NF2↑, 1,   NOTCH↓, 6,   NOTCH1↓, 4,   NOTCH3↑, 1,   Piezo1↑, 1,   Shh↓, 2,   Smo↓, 1,   STAT1↓, 2,   TumCG↓, 17,   TumCG↑, 1,   TumCP↓, 33,   tyrosinase↓, 1,   Wnt↓, 16,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

Alix/AIP‑1↓, 1,   AntiAg↓, 1,   AP-1↓, 2,   AP-1↝, 1,   ASAP2↓, 1,   AXL↓, 1,   Ca+2↓, 1,   Ca+2↑, 6,   Ca+2↝, 2,   CAFs/TAFs↓, 1,   Cdc42↓, 1,   E-cadherin↓, 4,   E-cadherin↑, 16,   EMT↓, 24,   FAK↓, 5,   p‑FAK↓, 1,   p‑FAK↑, 1,   ITGB1↓, 1,   LAMs↓, 1,   MALAT1↓, 1,   MET↓, 1,   MET↑, 1,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP13↓, 3,   MMP2↓, 29,   MMP2↝, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 34,   MMP9↑, 1,   MMPs↓, 11,   MUC4↓, 2,   N-cadherin↓, 8,   NEDD9↓, 1,   PDGF↓, 1,   Rac1↓, 2,   Rho↓, 1,   ROCK1↓, 1,   Sharpin↓, 1,   Slug↓, 3,   SMAD3↓, 1,   Snail↓, 10,   TET1↓, 1,   TGF-β↓, 6,   TGF-β↑, 1,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↓, 1,   TIMP2↑, 2,   TIMP3↑, 1,   TSC1↑, 2,   TSP-1↑, 1,   TumCI↓, 21,   TumCI↑, 2,   TumCMig↓, 17,   TumMeta↓, 16,   TumMeta↑, 2,   Twist↓, 9,   Tyro3↓, 1,   uPA↓, 11,   uPAR↓, 1,   Vim↓, 16,   Vim↑, 1,   Zeb1↓, 3,   α-SMA↓, 1,   α-tubulin↓, 2,   β-catenin/ZEB1↓, 14,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 25,   angioG↑, 1,   Endoglin↑, 1,   HIF-1↓, 2,   Hif1a↓, 23,   NO↓, 2,   PGI2↓, 1,   VEGF↓, 33,   VEGF↝, 1,   VEGFR2/KDR/Flk1↓, 4,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 2,   CLDN1↓, 2,   CLDN2↓, 1,   GLUT1↓, 4,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   MMP↓, 21,   NHE1↓, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↑, 1,   CD44↓, 2,   CD8+↑, 1,   cDC2↓, 1,   COX1↓, 1,   COX2/PTGS2↓, 25,   COX2/PTGS2↝, 1,   CXCL12↓, 2,   CXCR2↓, 1,   CXCR4↓, 6,   DR4↑, 2,   FOXP3↓, 1,   ICAM-1↓, 2,   IL1↓, 2,   IL1↑, 1,   IL10↓, 2,   IL10↑, 2,   IL1β↓, 1,   IL2↑, 2,   IL6↓, 16,   IL6↝, 1,   IL8↓, 2,   Imm↑, 1,   Inflam↓, 12,   IRAK1↓, 1,   LRIG1↑, 1,   MCP1/CCL2↓, 2,   MCT1↓, 1,   NF-kB↓, 40,   NF-kB↝, 1,   p‑NF-kB↑, 1,   NK cell↑, 1,   NLRP3↓, 1,   p65↓, 1,   p‑p65↓, 2,   PD-1↓, 1,   PD-L1↓, 2,   PGE2↓, 7,   PSA↓, 4,   PSA↝, 1,   SOCS-3↓, 1,   SOCS1↑, 1,   T-Cell↑, 2,   T-Cell↝, 1,   TCF↓, 2,   Th1 response↑, 1,   TNF-α↓, 5,   TNF-α↑, 2,   TNF-α↝, 1,   Treg lymp↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AR↓, 4,   AR↝, 1,   FGF21↓, 1,   PPARγ↓, 3,   PPARγ↑, 3,   RANKL↓, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 13,   BioAv↑, 14,   BioAv↝, 3,   BioEnh?, 1,   BioEnh↑, 1,   ChemoSen?, 2,   ChemoSen↑, 43,   ChemoSen⇅, 1,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 1,   CYP1A1↓, 2,   CYP1A2↓, 1,   CYP1B1↓, 1,   Dose?, 3,   Dose↓, 2,   Dose↑, 4,   Dose↝, 14,   Dose∅, 5,   eff↓, 5,   eff↑, 14,   eff↝, 1,   eff∅, 2,   Half-Life↓, 3,   Half-Life↑, 2,   Half-Life↝, 5,   MDR1↓, 3,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 1,   P450↓, 1,   RadioS↑, 15,   selectivity↑, 16,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALP↓, 1,   AR↓, 4,   AR↝, 1,   AST↓, 2,   BG↓, 1,   BP↓, 1,   BRAF↑, 1,   BRAF↝, 1,   BRCA1↑, 2,   CEA↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 13,   EGFR↑, 1,   EGFR↝, 1,   EZH2↓, 5,   FOXM1↓, 1,   HER2/EBBR2↓, 3,   hTERT/TERT↓, 5,   IL6↓, 16,   IL6↝, 1,   Maspin↑, 1,   Myc↓, 3,   NSE↓, 1,   PD-L1↓, 2,   PSA↓, 4,   PSA↝, 1,   TP53↑, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 8,   antiD↑, 1,   AntiTum↑, 4,   cachexia↓, 2,   cardioP↑, 4,   chemoP↑, 8,   chemoPv↑, 5,   ChemoSideEff↓, 2,   hepatoP↑, 3,   neuroP↑, 1,   OS↑, 4,   radioP↑, 1,   Remission↑, 1,   RenoP↑, 3,   Risk↓, 3,   TGFβR1↑, 1,   toxicity↓, 4,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 1,   TumVol↓, 5,   TumW↓, 3,  
Total Targets: 648

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 20,   Catalase↑, 10,   Fenton↓, 1,   GPx↑, 8,   GPx1↑, 1,   GSH↓, 1,   GSH↑, 11,   GSR↑, 1,   GSTs↑, 4,   H2O2↓, 2,   H2O2∅, 1,   HDL↑, 1,   HO-1↑, 7,   lipid-P↓, 4,   MDA↓, 4,   MPO↓, 1,   NOX↓, 1,   NQO1↑, 4,   NRF2↑, 12,   RNS↓, 2,   ROS↓, 27,   ROS↑, 2,   ROS⇅, 1,   mt-ROS↓, 1,   SOD↑, 11,   SOD1↑, 1,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   FPN↑, 1,   IronCh↑, 2,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

FIS1↓, 1,   Insulin↓, 1,   SIRT3↑, 2,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   5LO↝, 1,   adiP↑, 1,   AMPK↑, 4,   glucose↓, 1,   glucose↑, 1,   GlucoseCon↑, 1,   LDL↓, 2,   NAD↑, 1,   NADPH↓, 1,   PIP3↑, 1,   SIRT1↑, 4,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   BAX↓, 1,   Bcl-2↑, 1,   Casp3↓, 3,   iNOS↓, 4,   p38↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 6,   p‑Akt↓, 1,   p‑Akt↑, 2,   CREB↑, 1,   p‑CREB↑, 1,   ERK↓, 1,   ERK↑, 4,   IGF-1R↓, 1,   JAK↓, 1,   MAPK↓, 3,   MAPK↑, 2,   mTOR↓, 1,   mTOR↑, 1,   PDGFR-BB↓, 1,   PI3K↓, 1,   PI3K↑, 5,   p‑PI3K↓, 1,   PKCδ↑, 3,   PTEN↓, 8,   PTEN↑, 6,   p‑PTEN↓, 1,   p‑PTEN↑, 1,   STAT3↑, 1,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   FOXO1↝, 1,   FOXO3↑, 1,   HOTAIR↑, 1,   other↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP90↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   p62↓, 1,   PARK2↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   P53↓, 1,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↓, 1,   E2Fs↑, 1,   RB1↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

FGF↑, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 6,   AP-1↓, 1,   MMP13↓, 1,   MMP2↓, 1,   MMP9↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   eNOS↑, 2,   Hif1a↓, 1,   NO↓, 4,   NO↑, 1,   VCAM-1↓, 3,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 7,   GLUT1↑, 1,   GLUT4↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD40↓, 1,   COX2/PTGS2↓, 7,   ICAM-1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL1β↓, 6,   IL6↓, 6,   IL8↓, 2,   Imm↑, 2,   Inflam↓, 27,   IP-10/CXCL-10↓, 1,   NF-kB↓, 8,   NLRP3↓, 1,   PGE2↓, 1,   TLR1↓, 1,   TLR4↓, 1,   TNF-α↓, 7,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   Ach↑, 1,   BDNF↑, 1,   GABA↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   Aβ42↓, 2,   tau↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

FGF21↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 13,   BioAv↑, 11,   BioAv↝, 10,   BioAv∅, 1,   BioEnh↑, 1,   ChemoSen↑, 1,   CYP1A1↑, 1,   CYP1A2↑, 1,   Dose↝, 4,   Dose∅, 1,   eff↓, 1,   eff↑, 6,   GSTA1↑, 1,   Half-Life↝, 5,   Half-Life∅, 2,   P450↓, 1,   Synergy↑, 2,  

Clinical Biomarkers(tgid=22) ⓘ

anemia↓, 1,   BP↝, 1,   CRP↓, 1,   Ferritin↓, 1,   HemoG↑, 1,   IL6↓, 6,   LDH↓, 1,   RBC↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 1,   antiAll↑, 1,   AntiCan↓, 1,   AntiCan↑, 4,   AntiDiabetic↑, 2,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP↑, 11,   chemoP↑, 1,   chemoPv↑, 2,   cognitive↑, 8,   hepatoP↓, 1,   hepatoP↑, 6,   memory↑, 7,   neuroP↑, 17,   Stroke↓, 3,   toxicity↓, 4,   toxicity↝, 2,   toxicity∅, 2,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 4,   AntiFungal↓, 1,   AntiFungal↑, 1,   AntiViral↑, 4,   Bacteria↓, 3,   Bacteria↑, 1,   GutMicro↑, 2,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 2,  
Total Targets: 199

Scientific Paper Hit Count for: PTEN, phosphatase and tensin homolog; phosphatase and tensin homolog pseudogene 1
10 Thymoquinone
8 Curcumin
7 Baicalein
6 Resveratrol
5 Fisetin
5 Quercetin
4 Boron
4 Citric Acid
4 EGCG (Epigallocatechin Gallate)
3 Honokiol
3 Magnolol
3 Matrine
3 Melatonin
3 Pterostilbene
3 Shikonin
2 5-fluorouracil
2 Alpha-Lipoic-Acid
2 Berberine
2 Indole-3-carbinol
2 Ellagic acid
2 Ferulic acid
2 Gambogic Acid
2 Ginkgetin
2 Grapeseed extract
2 Isorhamnetin
2 Kaempferol
2 Lactoferrin/Talactoferrin
2 Nimbolide
2 Phycocyanin
2 doxorubicin
1 Coenzyme Q10
1 Silver-NanoParticles
1 Atorvastatin
1 Benzyl isothiocyanate
1 Phenethyl isothiocyanate
1 Allyl isothiocyanate
1 Boswellia (frankincense)
1 Carnosic acid
1 Capsaicin
1 Chrysin
1 Crocetin
1 Ursolic acid
1 Deguelin
1 diet FMD Fasting Mimicking Diet
1 Chemotherapy
1 diet Methionine-Restricted Diet
1 Diindolylmethane
1 Formononetin
1 Gallic acid
1 Ginkgolic acids
1 Genistein (soy isoflavone)
1 Hydrogen Gas
1 Isothiocyanates
1 Sulforaphane (mainly Broccoli)
1 Licorice
1 Luteolin
1 Lutein
1 Magnetic Fields
1 Neem
1 Propolis -bee glue
1 Piperine
1 Piperlongumine
1 Parthenolide
1 Gold NanoParticles
1 Rosmarinic acid
1 Silymarin (Milk Thistle) silibinin
1 Docetaxel
1 Urolithin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:267  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page